HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 78 filers reported holding HARROW HEALTH INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $65,000 | -54.5% | 4,539 | -39.4% | 0.00% | – |
Q2 2023 | $143,000 | +146.6% | 7,490 | +170.6% | 0.00% | – |
Q1 2023 | $58,000 | +1.8% | 2,768 | -28.2% | 0.00% | – |
Q4 2022 | $57,000 | +137.5% | 3,853 | +97.3% | 0.00% | – |
Q3 2022 | $24,000 | +84.6% | 1,953 | +5.4% | 0.00% | – |
Q2 2022 | $13,000 | -23.5% | 1,853 | -24.2% | 0.00% | – |
Q1 2022 | $17,000 | +6.2% | 2,444 | +31.9% | 0.00% | – |
Q4 2021 | $16,000 | -91.0% | 1,853 | -90.5% | 0.00% | – |
Q3 2021 | $178,000 | -57.1% | 19,579 | -56.1% | 0.00% | – |
Q2 2021 | $415,000 | +44.1% | 44,610 | +4.9% | 0.00% | – |
Q1 2021 | $288,000 | -1.7% | 42,513 | -0.4% | 0.00% | – |
Q4 2020 | $293,000 | +7225.0% | 42,671 | +5826.5% | 0.00% | – |
Q3 2020 | $4,000 | 0.0% | 720 | -1.0% | 0.00% | – |
Q2 2020 | $4,000 | +33.3% | 727 | 0.0% | 0.00% | – |
Q1 2020 | $3,000 | -50.0% | 727 | +1.0% | 0.00% | – |
Q4 2019 | $6,000 | +50.0% | 720 | -1.2% | 0.00% | – |
Q3 2019 | $4,000 | -33.3% | 729 | +1.2% | 0.00% | – |
Q2 2019 | $6,000 | +50.0% | 720 | 0.0% | 0.00% | – |
Q1 2019 | $4,000 | – | 720 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 3,065,416 | $21,029,000 | 2.75% |
Diametric Capital, LP | 252,774 | $1,734,000 | 1.38% |
Birchview Capital, LP | 180,000 | $1,235,000 | 0.71% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 118,389 | $812,000 | 0.61% |
Zebra Capital Management LLC | 58,062 | $398,000 | 0.50% |
Precision Wealth Strategies, LLC | 62,739 | $430,000 | 0.47% |
Sio Capital Management, LLC | 209,623 | $1,438,000 | 0.29% |
Uniplan Investment Counsel, Inc. | 505,746 | $3,469,000 | 0.24% |
CORRADO ADVISORS, LLC | 31,580 | $217,000 | 0.17% |
BARD ASSOCIATES INC | 287,250 | $1,970,000 | 0.16% |